About Ralitsa Larsen

This author has not yet filled in any details.
So far Ralitsa Larsen has created 9 blog entries.

From Supplier to Public Health Player: The Changing Role of Biopharma Companies

2020-08-21T11:05:43-04:00Thought Leadership|

Access challenges to cell and gene therapy are well documented. Precision’s Christina Poschen and David Carr discuss how some innovative manufacturers are moving away from the role of being purely a researcher and manufacturer and toward involvement at the point of diagnosis through manufacturing and delivery to patient access support in order to address those challenges head on.

(more…)

Webinar: Using HEOR Methods to Reduce Health Inequalities

2020-10-15T15:29:25-04:00Events|

Current social and political events have brought renewed attention to the levels of systemic inequalities faced by millions of minorities in the United States and around the world. Adding to the discussion, Precision will explore how innovative health economics and outcomes research (HEOR) methods can be leveraged to quantify the full value new treatments that improve health outcomes for underserved communities.

(more…)

Webinar: Gene Therapies In Hemophilia

2020-10-15T15:28:22-04:00Events|

As the first ‘big wave’ in the gene therapy space, onetime potentially curative treatments for hemophilia present a potential revolution for many thousands of patients. However, so far, gene therapies have targeted smaller indications and the prospect of treating much higher numbers at the price benchmarks already set may prove challenging for payers and health systems to provide access.
(more…)

Webinar: Optimizing Product Launch Market Access strategy and Gross-to-Net Modeling

2020-08-21T07:20:56-04:00Events|

Join Precision and Akara Group on Thursday, 8/6, 2020 | 12:00 PM EDT – 1:00 PM EDT for a special live, online discussion of best practices for pre-launch commercialization activities. Featuring Precision’s Brett DiNatale, learn about the latest advances in data, analytics, and technology, and understand how these latest advances can be used to improve decisions that impact GTN.
(more…)